Enzon to sell specialty pharma business

Sigma-Tau S.p.A. (Rome, Italy) will acquire the specialty pharmaceuticals business of Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) for $300

Read the full 171 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE